This interactive learning module is a self-directed educational activity, led by experts Dr. Michelle Sholzberg and Dr. Angela Weyand. Topics include new and emerging treatments, novel agents that are being developed, current clinical studies, and potential concerns of novel therapies. This activity is supported by an educational grant from Novo Nordisk.